Inst Diagnosti
Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hos… Read more
Inst Diagnosti (INDISA) - Total Assets
Latest total assets as of June 2025: CL$305.25 Billion CLP
Based on the latest financial reports, Inst Diagnosti (INDISA) holds total assets worth CL$305.25 Billion CLP as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Inst Diagnosti - Total Assets Trend (2014–2024)
This chart illustrates how Inst Diagnosti’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Inst Diagnosti - Asset Composition Analysis
Current Asset Composition (December 2024)
Inst Diagnosti's total assets of CL$305.25 Billion consist of 36.3% current assets and 63.7% non-current assets.
| Asset Category | Amount (CLP) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CL$0.00 | 3.9% |
| Accounts Receivable | CL$60.21 Billion | 22.1% |
| Inventory | CL$2.76 Billion | 1.0% |
| Property, Plant & Equipment | CL$0.00 | 0.0% |
| Intangible Assets | CL$8.92 Billion | 3.3% |
| Goodwill | CL$0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how Inst Diagnosti's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Inst Diagnosti's current assets represent 36.3% of total assets in 2024, a decrease from 37.6% in 2014.
- Cash Position: Cash and equivalents constituted 3.9% of total assets in 2024, down from 11.0% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 22.1% of total assets.
Inst Diagnosti Competitors by Total Assets
Key competitors of Inst Diagnosti based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
Inst Diagnosti - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Inst Diagnosti generates 0.88x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Inst Diagnosti generates $ 2.67 in net profit.
Inst Diagnosti - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.00 | 1.19 | 1.31 |
| Quick Ratio | 0.97 | 1.15 | 1.27 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CL$-327.44 Million | CL$ 15.60 Billion | CL$ 17.89 Billion |
Inst Diagnosti - Advanced Valuation Insights
This section examines the relationship between Inst Diagnosti's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.55 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -1.5% |
| Total Assets | CL$272.44 Billion |
| Market Capitalization | $294.91 Million USD |
Valuation Analysis
Below Book Valuation: The market values Inst Diagnosti's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Inst Diagnosti's assets decreased by 1.5% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Inst Diagnosti (2014–2024)
The table below shows the annual total assets of Inst Diagnosti from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CL$272.44 Billion | -1.50% |
| 2023-12-31 | CL$276.57 Billion | +1.32% |
| 2022-12-31 | CL$272.96 Billion | +18.23% |
| 2021-12-31 | CL$230.88 Billion | +26.35% |
| 2020-12-31 | CL$182.72 Billion | +8.45% |
| 2019-12-31 | CL$168.49 Billion | +3.05% |
| 2018-12-31 | CL$163.50 Billion | +2.28% |
| 2017-12-31 | CL$159.86 Billion | +3.66% |
| 2016-12-31 | CL$154.22 Billion | +13.88% |
| 2015-12-31 | CL$135.42 Billion | +21.24% |
| 2014-12-31 | CL$111.69 Billion | -- |